L707-2175 Screening compound: 2-[7-(azepane-1-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]-N-benzylacetamide

L707-2175 Screening compound: 2-[7-(azepane-1-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]-N-benzylacetamide
L707-2175 Screening compound: 2-[7-(azepane-1-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]-N-benzylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L707-2175
2-[7-(azepane-1-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]-N-benzylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L707-2175

Molecular Formula

C25H31N3O4S (C25 H31 N3 O4 S)

Compound Name

2-[7-(azepane-1-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]-N-benzylacetamide

IUPAC name

2-[7-(azepane-1-sulfonyl)-2-oxo-2345-tetrahydro-1H-1-benzazepin-1-yl]-N-benzylacetamide

SMILES

O=C(CN(c(cc1)c(CCC2)cc1S(N1CCCCCC1)(=O)=O)C2=O)NCc1ccccc1

InChI

InChI=1S/C25H31N3O4S/c29-24(26-18-20-9-4-3-5-10-20)19-28-23-14-13-22(17-21(23)11-8-12-25(28)30)33(31,32)27-15-6-1-2-7-16-27/h3-5,9-10,13-14,17H,1-2,6-8,11-12,15-16,18-19H2,(H,26,29)

InChI Key

ROIJNFRXSRNRAE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27472138

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

469.6

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.735

Distribution Coefficient, logD

3.735

Water Solubility, LogSw

-4.01

Polar Surface Area

72.463

Acid Dissociation Constant (pKa)

13.00

Base Dissociation Constant (pKb)

-1.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.00

L707-2175 in Drug Discovery

Included in Screening Libraries

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L707-2175 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L707-2175?
Check Price and Availability of L707-2175, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L707-2175 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L707-2175
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L707-2175
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L707-2175 available by request